The alleviation of acute and chronic kidney injury by human Wharton's jelly-derived mesenchymal stromal cells triggered by ischemia-reperfusion injury via an endocrine mechanism

Cytotherapy

Volumn 14, Issue 10, 2012, Pages 1215-1227

  Du, Tao ^a   Cheng, Jun ^a   Zhong, Liang ^a   Zhao, Xin Feng ^a   Zhu, Jiang ^a   Zhu, Ying Jian ^a   Liu, Guo Hua ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

hepatocyte growth factor; ischemia reperfusion injury; mesenchymal stromal cells; tubular cells; Wharton's jelly

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BROXURIDINE; COLLAGEN; CREATININE; HEME OXYGENASE 1; INTERLEUKIN 10; NITROGEN; PROTEIN KINASE B; SCATTER FACTOR;

ACUTE KIDNEY FAILURE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL LABELING; CELL PROLIFERATION; CELL TRANSPLANTATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; KIDNEY FIBROSIS; KIDNEY INJURY; KIDNEY ISCHEMIA; KIDNEY TUBULE CELL; MALE; MESENCHYMAL STROMA CELL; MESENCHYMAL STROMA CELL TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CONTENT; RAT; REAL TIME POLYMERASE CHAIN REACTION; REPERFUSION INJURY; SIGNAL TRANSDUCTION; UPREGULATION; UREA NITROGEN BLOOD LEVEL;

EID: 84867629610     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.3109/14653249.2012.711471     Document Type: Article

References (45)

1. Devarajan P. Update on mechanisms of ischemic acute kidney injury. J Am Soc Nephrol. 2006; 17: 1503-20.
2. Bonventre J V. Dedifferentiation and proliferation of surviving epithelial cells in acute renal failure. J Am Soc Nephrol. 2003; 14(Suppl 1): S55-61.
3. Macedo E, Bouchard J, Mehta RL. Renal recovery following acute kidney injury. Curr Op Crit Care. 2008; 14: 660-5.
4. Baer P C, Geiger H. Mesenchymal stem cell interactions with growth factors on kidney repair. Curr Opin Nephrol Hypertens. 2010; 19: 1-6.
5. Duffield J S, Park K M, Hsiao L L, Kelley V R, Scadden D T, Ichimura T, et al. Restoration of tubular epithelial cells during repair of the postischemic kidney occurs independently of bone marrow-derived stem cells. J Clin Invest. 2005; 115: 1743-55.
6. Togel F, Hu Z, Weiss K, Isaac J, Lange C, Westenfelder C. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiationindependent mechanisms. Am J Physiol Renal Physiol. 2005; 289: F31-42.
7. Bi B, Schmitt R, Israilova M, Nishio H, Cantley L G. Stromal cells protect against acute tubular injury via an endocrine effect. J Am Soc Nephrol. 2007; 18: 2486-96.
8. Togel F E, Westenfelder C. Mesenchymal stem cells: A new therapeutic tool for AKI. Nature Rev Nephrol. 2010; 6: 179-83.
9. Caplan AI, Dennis J E. Mesenchymal stem cells as trophic mediators. J Cell Biochem. 2006; 98: 1076-84.
10. Rao M S, Mattson M P. Stem cells and aging: Expanding the possibilities. Mech Ageing Dev. 2001; 122: 713-34.
11. Can A, Karahuseyinoglu S. Concise review. Human umbilical cord stroma with regard to the source of fetus-derived stem cells. Stem Cells. 2007; 25: 2886-95.
12. Mitchell KE, Weiss ML, Mitchell BM, Martin P, Davis D, Morales L, et al. Matrix cells from Wharton's jelly form neurons and glia. Stem Cells. 2003; 21: 50-60.
13. Troyer D L, Weiss M L. Wharton's jelly-derived cells are a primitive stromal cell population. Stem Cells. 2008; 26: 591-9.
14. ML, Anderson C, Medicetty S, Seshareddy KB, Weiss RJ, VanderWerff I, et al. Immune properties of human umbilical cord Wharton's jelly-derived cells. Stem Cells. 2008; 26: 2865-74.
15. Baksh D, Yao R, Tuan R S. Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells. 2007; 25: 1384-92.
16. Boor P, Ostendorf T, Floege J. Renal fibrosis: Novel insights into mechanisms and therapeutic targets. Nat Rev Nephrol. 2010; 6: 643-56.
17. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006; 8: 315-7.
18. Bonegio R, Lieberthal W. Role of apoptosis in the pathogenesis of acute renal failure. Curr Opin Nephrol Hypertens. 2002; 11: 301-8.
19. Kunter U, Rong S, Djuric Z, Boor P, Muller-Newen G, Yu D, et al. Transplanted mesenchymal stem cells accelerate glomerular healing in experimental glomerulonephritis. J Am Soc Nephrol. 2006; 17: 2202-12.
20. Morigi M, Introna M, Imberti B, Corna D, Abbate M, Rota C, et al. Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice. Stem Cells. 2008; 26: 2075-82.
21. Bonventre JV, Zuk A. Ischemic acute renal failure: An infl ammatory disease? Kidney Int. 2004; 66: 480-5.
22. Ryter SW, Alam J, Choi A M. Heme oxygenase-1/carbon monoxide: From basic science to therapeutic applications. Physiol Rev. 2006; 86: 583-650.
23. Deng J, Kohda Y, Chiao H, Wang Y, Hu X, Hewitt SM, et al. Interleukin-10 inhibits ischemic and cisplatin-induced acute renal injury. Kidney Int. 2001; 60: 2118-28.
24. Datta SR, Brunet A, Greenberg ME. Cellular survival: A play in three Akts. Genes Dev. 1999; 13: 2905-27.
25. Xie L, Zheng X, Qin J, Chen Z, Jin Y, Ding W. Role of PI3-kinase/Akt signalling pathway in renal function and cell proliferation after renal ischaemia/reperfusion injury in mice. Nephrology (Carlton). 2006; 11: 207-12.
26. Lieberthal W, Fuhro R, Andry CC, Rennke H, Abernathy VE, Koh JS, et al. Rapamycin impairs recovery from acute renal failure: Role of cell-cycle arrest and apoptosis of tubular cells. Am J Physiol Renal Physiol. 2001; 281: F693-706.
27. Humphreys BD, Valerius MT, Kobayashi A, Mugford JW, Soeung S, Duffield JS, et al. Intrinsic epithelial cells repair the kidney after injury. Cell Stem Cell. 2008; 2: 284-91.
28. Humphreys B D, Czerniak S, Dirocco D P, Hasnain W, Cheema R, Bonventre JV. Repair of injured proximal tubule does not involve specialized progenitors. Proc Natl Acad Sci USA. 2011; 108: 9226-31.
29. Liu K D, Brakeman P R. Renal repair and recovery. Crit Care Med. 2008; 36: S187-92.
30. Hammerman MR, Miller SB. Therapeutic use of growth factors in renal failure. J Am Soc Nephrol. 1994; 5: 1-11.
31. Nigam S, Lieberthal W. Acute renal failure. III. The role of growth factors in the process of renal regeneration and repair. Am J Physiol Renal Physiol. 2000; 279: F3-11.
32. Liu Y. Hepatocyte growth factor promotes renal epithelial cell survival by dual mechanisms. Am J Physiol. 1999; 277: F624-33.
33. Vargas G A, Hoefl ich A, Jehle P M. Hepatocyte growth factor in renal failure: Promise and reality. Kidney Int. 2000; 57: 1426-36.
34. Liu Y. Hepatocyte growth factor and the kidney. Curr Opin Nephrol Hypertens. 2002; 11: 23-30.
35. Giannopoulou M, Dai C, Tan X, Wen X, Michalopoulos GK, Liu Y. Hepatocyte growth factor exerts its anti-infl ammatory action by disrupting nuclear factor-kappaB signaling. Am J Pathol. 2008; 173: 30-41.
36. Mizuno S, Nakamura T. Prevention of neutrophil extravasation by hepatocyte growth factor leads to attenuations of tubular apoptosis and renal dysfunction in mouse ischemic kidneys. Am J Pathol. 2005; 166: 1895-905.
37. Kamimoto M, Mizuno S, Matsumoto K, Nakamura T. Hepatocyte growth factor prevents multiple organ injuries in endotoxemic mice through a heme oxygenase-1- dependent mechanism. Biochem Biophys Res Comm. 2009; 380: 333-7.
38. Rutella S, Bonanno G, Procoli A, Mariotti A, d e Ritis D G, Curti A, et al. Hepatocyte growth factor favors monocyte differentiation into regulatory interleukin (IL)-10 -IL-12 low/neg accessory cells with dendritic-cell features. Blood. 2006; 108: 218-27.
39. Liu Y. Hepatocyte growth factor in kidney fibrosis: Therapeutic potential and mechanisms of action. Am J Physiol Renal Physiol. 2004; 287: F7-16.
40. Nakamura T, Mizuno S. The discovery of hepatocyte growth factor (HGF) and its significance for cell biology, life sciences and clinical medicine. Proc Japan Acad Series B. 2010; 86: 588-610.
41. Morigi M, Rota C, Montemurro T, Montelatici E, Lo Cicero V, Imberti B, et al. Life-sparing effect of human cord blood-mesenchymal stem cells in experimental acute kidney injury. Stem Cells. 2010; 28: 513-22.
42. Ratajczak MZ, Kucia M, Jadczyk T, Greco NJ, Wojakowski W, Tendera M, et al. Pivotal role of paracrine effects in stem cell therapies in regenerative medicine: Can we translate stem cell-secreted paracrine factors and microvesicles into better therapeutic strategies? Leukemia. 2011; 26: 1166-1173.
43. Camussi G, Deregibus M C, Tetta C. Paracrine/endocrine mechanism of stem cells on kidney repair: Role of microvesiclemediated transfer of genetic information. Curr Opin Nephrol Hyperten. 2010; 19: 7-12.
44. Ishani A, Xue JL, Himmelfarb J, Eggers PW, Kimmel PL, Molitoris BA, et al. Acute kidney injury increases risk of ESRD among elderly. J Am Soc Nephrol. 2009; 20: 223-8.
45. Moodley Y, Atienza D, Manuelpillai U, Samuel CS, Tchongue J, Ilancheran S, et al. Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury. Am J Pathol. 2009; 175: 303-13.